BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33450374)

  • 1. Efficient iron utilization compensates for loss of extracellular matrix of ovarian cancer spheroids.
    Wang Q; Gu T; Ma L; Bu S; Zhou W; Mao G; Wang LL; Guo Y; Lai D
    Free Radic Biol Med; 2021 Feb; 164():369-380. PubMed ID: 33450374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
    Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
    Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.
    Carduner L; Picot CR; Leroy-Dudal J; Blay L; Kellouche S; Carreiras F
    Exp Cell Res; 2014 Jan; 320(2):329-42. PubMed ID: 24291221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM.
    Yang Z; Liu Y; Wei X; Zhou X; Gong C; Zhang T; Jin P; Xu S; Ma D; Gao Q
    Curr Cancer Drug Targets; 2015; 15(3):215-26. PubMed ID: 25619386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
    Zhang Q; Yu S; Lam MMT; Poon TCW; Sun L; Jiao Y; Wong AST; Lee LTO
    J Exp Clin Cancer Res; 2019 Mar; 38(1):116. PubMed ID: 30845964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
    Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
    Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.
    Peart T; Ramos Valdes Y; Correa RJ; Fazio E; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Oncotarget; 2015 Sep; 6(26):22424-38. PubMed ID: 26068970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer: in vitro model using cancer stem cell enriched ovarian cancer spheroids.
    He M; Wang D; Zou D; Wang C; Lopes-Bastos B; Jiang WG; Chester J; Zhou Q; Cai J
    Oncotarget; 2016 Dec; 7(52):86374-86387. PubMed ID: 27863439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
    Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
    Pan Y; Robertson G; Pedersen L; Lim E; Hernandez-Herrera A; Rowat AC; Patil SL; Chan CK; Wen Y; Zhang X; Basu-Roy U; Mansukhani A; Chu A; Sipahimalani P; Bowlby R; Brooks D; Thiessen N; Coarfa C; Ma Y; Moore RA; Schein JE; Mungall AJ; Liu J; Pecot CV; Sood AK; Jones SJ; Marra MA; Gunaratne PH
    Oncotarget; 2016 May; 7(18):25930-48. PubMed ID: 27036018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis.
    Laski J; Singha B; Wang X; Valdés YR; Collins O; Shepherd TG
    J Ovarian Res; 2020 May; 13(1):58. PubMed ID: 32393385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer.
    Ding Y; Labitzky V; Legler K; Qi M; Schumacher U; Schmalfeldt B; Stürken C; Oliveira-Ferrer L
    Mol Oncol; 2021 Dec; 15(12):3578-3595. PubMed ID: 34060699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.
    Correa RJ; Peart T; Valdes YR; DiMattia GE; Shepherd TG
    Carcinogenesis; 2012 Jan; 33(1):49-58. PubMed ID: 22045027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.
    Gunay G; Kirit HA; Kamatar A; Baghdasaryan O; Hamsici S; Acar H
    Gynecol Oncol; 2020 Nov; 159(2):563-572. PubMed ID: 32958270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis.
    Shield K; Riley C; Quinn MA; Rice GE; Ackland ML; Ahmed N
    J Carcinog; 2007 Jun; 6():11. PubMed ID: 17567918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis.
    Azimian-Zavareh V; Hossein G; Ebrahimi M; Dehghani-Ghobadi Z
    Exp Cell Res; 2018 Aug; 369(1):90-104. PubMed ID: 29753625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanical microenvironment regulates ovarian cancer cell morphology, migration, and spheroid disaggregation.
    McKenzie AJ; Hicks SR; Svec KV; Naughton H; Edmunds ZL; Howe AK
    Sci Rep; 2018 May; 8(1):7228. PubMed ID: 29740072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.
    Burleson KM; Hansen LK; Skubitz AP
    Clin Exp Metastasis; 2004; 21(8):685-97. PubMed ID: 16035613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.